US Broker Ratings

STERIS plc (STE): Investor Outlook on a Leading Infection Prevention Giant with a 16.63% Upside

STERIS plc (NYSE: STE), a key player in the healthcare sector with a market cap of $22.19 billion, is a formidable force in the medical devices industry. With its headquarters..

Edwards Lifesciences Corporation (EW) Stock Analysis: Evaluating the Healthcare Giant’s 5.9% Potential Upside

Edwards Lifesciences Corporation (NYSE: EW) stands at the forefront of the medical devices industry, specializing in cutting-edge cardiovascular disease treatments. With a presence spanning the United States, Europe, Japan, and..

Quest Diagnostics (DGX) Stock Analysis: A Look at Its 10% Upside Potential and Solid Dividend Yield

For individual investors searching for a steady player in the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) presents a compelling case. With a market capitalization of $18.63 billion, Quest Diagnostics..

Smith & Nephew SNATS, Inc. (SNN): Valuation Insights and Growth Potential with a 9.88% Upside

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the medical devices industry, is capturing the attention of investors with its promising growth prospects and a potential upside..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 21% Upside Potential in the Healthcare Sector

For investors with a keen interest in the healthcare sector, Alcon Inc. (ALC) presents an intriguing opportunity. As a leading player in the medical instruments and supplies industry, Alcon is..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 34.74% Potential Upside

Universal Health Services, Inc. (NYSE: UHS) stands as a notable player in the healthcare sector, particularly within the medical care facilities industry. As of the latest market data, the company..

CVS Health Corporation (CVS) Stock Analysis: A Prescription for Potential Upside with a 28.68% Growth Target

CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, offers an intriguing investment opportunity with a potential upside of 28.68%. As an established leader in the healthcare..

Medtronic plc (MDT): Analyst Consensus Reveals Potential 7.78% Upside for Investors

Medtronic plc (NYSE: MDT), a titan in the medical devices industry, presents an intriguing opportunity for investors seeking stability combined with growth potential. With a market capitalization of $114.81 billion,..

Centene Corporation (CNC) Stock Analysis: Uncovering a Potential 173.70% Upside

Investors with an eye on the healthcare sector may find Centene Corporation (CNC) a compelling opportunity, especially given the stock’s potential upside of 173.70% based on current analyst target prices...

Incyte Corporation (INCY) Stock Analysis: Unveiling a 10.74% Potential Upside with a Robust Pipeline

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, continues to capture investor interest with its strong portfolio of therapeutics and potential upside of 10.74%. With a market..

AstraZeneca PLC (AZN) Investor Outlook: Examining a 22.38% Potential Upside

AstraZeneca PLC (AZN), a titan in the healthcare sector and a leader among general drug manufacturers, presents a compelling investment opportunity. With a market capitalization of $214.36 billion, this UK-based..

Sanofi (SNY)

⚠️ No article content returned.

..

UnitedHealth Group (UNH) Stock Report: Analyzing a 36.3% Potential Upside Amidst Healthcare Growth

UnitedHealth Group Incorporated (NYSE: UNH), a leader in the healthcare sector, continues to attract investor attention with its robust market presence and intriguing financial metrics. With a market capitalization of..

Summit Therapeutics Inc. (SMMT) Investor Outlook: Analyst Consensus Indicates 32% Upside Potential

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, has been capturing investor attention with its innovative approach to drug development and significant market momentum. With a..

Boston Scientific Corporation (BSX) Stock Report: Strong Buy Ratings Signal 13.42% Potential Upside

Boston Scientific Corporation (NYSE: BSX) stands tall as a leader in the healthcare sector, specifically within the medical devices industry. With its 2023 market cap soaring to an impressive $153.33..

Baxter International Inc. (BAX) Stock Analysis: Unpacking a 38% Potential Upside in the Healthcare Sector

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector, stands at an intriguing juncture for investors. With a market capitalization of $14.25 billion, the company is a prominent..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: A 32% Upside Amidst Market Volatility

West Pharmaceutical Services, Inc. (NYSE: WST) has long been a stalwart in the healthcare sector, specializing in the design and manufacture of containment and delivery systems for injectable drugs and..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring a 13.75% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the Diagnostics & Research industry. With a robust market capitalization of $20.4 billion, Labcorp..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unpacking an 18% Potential Upside in the Healthcare Sector

IQVIA Holdings, Inc. (NYSE: IQV) stands out in the healthcare sector, not only for its critical role in diagnostics and research but also for its promising stock potential. The company’s..

Abbott Laboratories (ABT) Stock Analysis: A Healthcare Giant with 14% Potential Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, continues to capture investor attention with its robust market position and promising growth potential. With a market capitalization of $215.17..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds